Search database
LIST OPTIONS
Filter
15
Filtered Results: 15
Text search: mycology laboratories
Featured
Language
Document type
No document type
8
Guidelines
4
Studies & Reports
3
Countries / Regions
India
2
Rwanda
1
Mozambique
1
Global
1
Latin America and the Carribbean
1
Tanzania
1
North America
1
East and Southern Africa
1
Ethiopia
1
Authors & Publishers
World Health Organization WHO
5
Aboud S., R. Mdegela
1
Cambridge University Press
1
Cheesbrough, M.
1
Global Antibiotic Resistance Partnership—Tanzania Working Group
1
Indian Council of Medical Research
1
Jahit S, David WD
1
Ministry of Health & Family Welfare India
1
Ministry of Health, Rwanda & Rwanda Biomedical Centre
1
National Centre for Disease Control
1
National Centre for Disease Control - Delhi
1
The Ethiopian Public Health Institute
1
World Bank, et al.
1
World Health Organization
1
Всемирная организация здравоохранения
1
Publication Years
Category
General Guidelines
3
Studies & Reports
3
Guidelines
2
Snakebites
1
Medical Devices & Equipment
1
Policies
1
Drugs & Medical Equipment
1
Health Systems
1
NTDs & Others
1
Toolboxes
Biosafety
1
Surveillance
1
Opportunistic Infections
1
Studies
1
Essential Medicines & Devices Lists
1
Studies & Reports
1
Leptospirosis
1
General
1

District Laboratory Practice in Tropical Countries Part-2

Cheesbrough, M. Cambridge University Press (2006) C4
Ethiopia Antimicrobial Resistance Surveillance Plan
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing of yeast
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases. The List is divid... more
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from studies in progress of high incidences of histoplasm... more
The 2010-2011 National Annual Report on HIV program presents the progress in implementing the strategies and activities articulated in the National Strategic Plan on HIV and AIDS 2009-2012 commonly referred to as the HIV NSP. The report presents consolidated information regarding the outputs in the ... more

Tuberculosis laboratory biosafety manual. (Russian Version)

World Health Organization Всемирная организация здравоохранения (2013) C_WHO
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.

Situation Analysis and Recommendation: Antibiotic Use and Resistance in Tanzania

Aboud S., R. Mdegela Global Antibiotic Resistance Partnership—Tanzania Working Group (2015) C2
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ... more
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ... more
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments... more
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Diagnosis, Case Management Prevention and Control of Leptospirosis